FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2990478843> ?p ?o ?g. }

• W2990478843 abstract "Abstract Nivolumab improves the prognosis of non-small cell lung cancer (NSCLC) but can cause immune-related adverse events (irAEs). Reports have indicated longer progression-free survivals (PFSs) in patients with irAEs than in those without irAEs. We reported associations between programmed death ligand-1 (PD-L1) single nucleotide polymorphisms (SNPs) and PFS after nivolumab treatment. We hypothesized that adverse events might be associated with the SNPs of PD-L1. We analyzed data from 111 patients with NSCLC treated with nivolumab. The response rate was 14%, and the median PFS was 68 days. We found patients with the adverse event of low free tetraiodothyronine (fT4) had significantly longer PFSs than those without low fT4 (not reached vs 67 days; hazard ratio [HR], 0.297; P = 0.010). Moreover, median overall survival was longer in patients with low fT4 than those without low fT4 (not reached vs 556 days, HR, 0.139; P = 0.020). Patients with the T allele of rs1411262 (P = 0.0073) and with the A allele of rs822339 (P = 0.0204) developed low fT4. Patients with the T/T genotype had longer PFSs than with those with the C/T and C/C genotypes of rs1411262 (165 vs. 67 days, HR, 1.65; P = 0.040), and those with the A/A genotype had longer PFSs than those with the A/G and G/G genotypes of rs822339 (182 vs. 67 days, HR, 1.76; P = 0.025). In the patients with advanced NSCLC, low fT4 after nivolumab treatment was associated with significantly longer PFSs. The SNPs of PD-L1 may be associated with the adverse events of nivolumab." @default.
• W2990478843 created "2019-12-05" @default.
• W2990478843 creator A5001796613 @default.
• W2990478843 creator A5018537494 @default.
• W2990478843 creator A5033969315 @default.
• W2990478843 creator A5045527646 @default.
• W2990478843 creator A5048538074 @default.
• W2990478843 creator A5049415919 @default.
• W2990478843 creator A5052560304 @default.
• W2990478843 creator A5065027118 @default.
• W2990478843 creator A5071759999 @default.
• W2990478843 creator A5090487149 @default.
• W2990478843 date "2019-11-19" @default.
• W2990478843 modified "2023-10-18" @default.
• W2990478843 title "Clinical impact of low serum free T4 in patients with non-small cell lung cancer treated with nivolumab" @default.
• W2990478843 cites W1947599571 @default.
• W2990478843 cites W1976135727 @default.
• W2990478843 cites W1982488143 @default.
• W2990478843 cites W1985369577 @default.
• W2990478843 cites W1988331425 @default.
• W2990478843 cites W2037056753 @default.
• W2990478843 cites W2049553585 @default.
• W2990478843 cites W2052738222 @default.
• W2990478843 cites W2054695890 @default.
• W2990478843 cites W2062963786 @default.
• W2990478843 cites W2079831662 @default.
• W2990478843 cites W2085604821 @default.
• W2990478843 cites W2104347254 @default.
• W2990478843 cites W2109653150 @default.
• W2990478843 cites W2119198740 @default.
• W2990478843 cites W2154086531 @default.
• W2990478843 cites W2156353875 @default.
• W2990478843 cites W2158840473 @default.
• W2990478843 cites W2179179825 @default.
• W2990478843 cites W2291675306 @default.
• W2990478843 cites W2305396859 @default.
• W2990478843 cites W2310054409 @default.
• W2990478843 cites W2508205285 @default.
• W2990478843 cites W2603352326 @default.
• W2990478843 cites W2607272476 @default.
• W2990478843 cites W2635951006 @default.
• W2990478843 cites W2759963646 @default.
• W2990478843 cites W2762777471 @default.
• W2990478843 cites W2900914533 @default.
• W2990478843 doi "https://doi.org/10.1038/s41598-019-53327-7" @default.
• W2990478843 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6864095" @default.
• W2990478843 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31745135" @default.
• W2990478843 hasPublicationYear "2019" @default.
• W2990478843 type Work @default.
• W2990478843 sameAs 2990478843 @default.
• W2990478843 citedByCount "11" @default.
• W2990478843 countsByYear W29904788432020 @default.
• W2990478843 countsByYear W29904788432021 @default.
• W2990478843 countsByYear W29904788432022 @default.
• W2990478843 countsByYear W29904788432023 @default.
• W2990478843 crossrefType "journal-article" @default.
• W2990478843 hasAuthorship W2990478843A5001796613 @default.
• W2990478843 hasAuthorship W2990478843A5018537494 @default.
• W2990478843 hasAuthorship W2990478843A5033969315 @default.
• W2990478843 hasAuthorship W2990478843A5045527646 @default.
• W2990478843 hasAuthorship W2990478843A5048538074 @default.
• W2990478843 hasAuthorship W2990478843A5049415919 @default.
• W2990478843 hasAuthorship W2990478843A5052560304 @default.
• W2990478843 hasAuthorship W2990478843A5065027118 @default.
• W2990478843 hasAuthorship W2990478843A5071759999 @default.
• W2990478843 hasAuthorship W2990478843A5090487149 @default.
• W2990478843 hasBestOaLocation W29904788431 @default.
• W2990478843 hasConcept C104317684 @default.
• W2990478843 hasConcept C121608353 @default.
• W2990478843 hasConcept C126322002 @default.
• W2990478843 hasConcept C135763542 @default.
• W2990478843 hasConcept C143998085 @default.
• W2990478843 hasConcept C153209595 @default.
• W2990478843 hasConcept C197934379 @default.
• W2990478843 hasConcept C207103383 @default.
• W2990478843 hasConcept C2776256026 @default.
• W2990478843 hasConcept C2777701055 @default.
• W2990478843 hasConcept C2780030458 @default.
• W2990478843 hasConcept C44249647 @default.
• W2990478843 hasConcept C54355233 @default.
• W2990478843 hasConcept C71924100 @default.
• W2990478843 hasConcept C86803240 @default.
• W2990478843 hasConcept C90924648 @default.
• W2990478843 hasConceptScore W2990478843C104317684 @default.
• W2990478843 hasConceptScore W2990478843C121608353 @default.
• W2990478843 hasConceptScore W2990478843C126322002 @default.
• W2990478843 hasConceptScore W2990478843C135763542 @default.
• W2990478843 hasConceptScore W2990478843C143998085 @default.
• W2990478843 hasConceptScore W2990478843C153209595 @default.
• W2990478843 hasConceptScore W2990478843C197934379 @default.
• W2990478843 hasConceptScore W2990478843C207103383 @default.
• W2990478843 hasConceptScore W2990478843C2776256026 @default.
• W2990478843 hasConceptScore W2990478843C2777701055 @default.
• W2990478843 hasConceptScore W2990478843C2780030458 @default.
• W2990478843 hasConceptScore W2990478843C44249647 @default.
• W2990478843 hasConceptScore W2990478843C54355233 @default.
• W2990478843 hasConceptScore W2990478843C71924100 @default.
• W2990478843 hasConceptScore W2990478843C86803240 @default.
• W2990478843 hasConceptScore W2990478843C90924648 @default.
• W2990478843 hasIssue "1" @default.

• next